查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829509

一次性生物製程市場（按產品類型、工作流程階段、生物處理模式、應用和終端用戶分類）—2025-2032 年全球預測

Single-use Bioprocessing Market by Product Type, Workflow Stage, Bioprocess Mode, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年一次性生物製程市場規模將成長至 597.7 億美元，複合年成長率為 16.19%。

主要市場統計數據
基準年2024年 179.9億美元
預計2025年 208.1億美元
預測年份：2032年 597.7億美元
複合年成長率（%） 16.19%

一次性生物製程技術以及推動全球生物製造領導者做出策略決策的市場動態的高階主管介紹

一次性生物製程已從實驗室方法發展成為生技藥品開發和商業化生產的核心製造模式。近期趨勢——技術改進、監管機構對一次性技術的認可以及營運重點的變化——加速了開發商、合約服務供應商和成熟製藥商的興趣。本介紹概述了一次性系統如今的重要性。一次性系統可降低交叉污染的風險，實現快速的宣傳活動週期，並提供模組化設計以支援靈活的生產佈局。

當企業在速度需求與嚴格的品管之間尋求平衡時，一次性解決方案的利弊需要仔細評估。資本規劃、材料供應可靠性以及與現有不銹鋼資產的整合是影響實施時間表的實際考慮因素。引言還預覽了分析過程中反覆出現的主題，包括生命週期永續性、數位儀器和感測器、填充-精加工的去中心化，以及供應商作為系統整合商而非組件供應商的角色演變。

讀者會發現，評估技術不僅要孤立地進行，更要將其置於更廣泛的生物製造生態系統中，才能明確價值所在和風險所在。後續章節將在此基礎上，探討推動技術應用的變革性轉變、貿易政策變化的影響、需求的細微細分，以及經營團隊在製定一次性策略時必須考慮的區域和競爭動態。

再形成一次性生物製程的新技術和營運曲折點，包括數位整合、模組化設計和永續性促進因素

在技​​術、監管和商業性力量融合的推動下，一次性生物製程領域正經歷一段轉型期。材料科學和感測器微型化的進步正在提升一次性組件的可靠性和分析能力，從而實現更嚴格的製程控制和更可重複的結果。同時，包括增強的連接性、嵌入式探頭和遠端監控在內的數位整合正在使一次性系統與現代自動化框架相容，從而降低了在受監管的生產環境中部署的門檻。

營運模式也在改變。製造商不再投資大型、固定容量的不銹鋼設備，而是青睞模組化、撬裝的解決方案，這些解決方案可以橫向擴展以滿足不斷變化的需求。這種變化支持快速的產品生命週期轉換和合約製造安排，在這些安排中，快速轉換和短期靈活性至關重要。永續性問題和生命週期評估方法正在重新強調在可行的情況下重複使用材料，同時也認知到一次性用品在契約製造空間內可以節省能源和水資源。

此外，供應鏈韌性已成為採購議程的首要議題。業界對此作出了回應，在某些領域整合了供應商，在其他領域則建立了更深的夥伴關係關係，供應商提供整合系統、檢驗支援和庫存管理服務。這種轉變促使生物製造商重新評估供應商選擇標準、技術轉移管治模式和投資重點，以平衡短期敏捷性和長期業務永續營運。

全面評估 2025 年美國預期關稅將如何影響一次性生物製程供應鏈、籌資策略和成本結構

美國預計2025年實施的關稅和貿易政策調整可能會對一次性供應鏈產生連鎖反應，影響籌資策略和庫存管理，但不會改變一次性產品的基本價值提案。關稅主導的成本壓力可能促使製造商重新考慮其供應商多元化策略，盡可能優先考慮國內採購方案，並協商簽訂長期供應協議以平滑價格波動。此類調整可能會導致前置作業時間發生變化，並更加重視二級供應商的資格，以保持連續性。

重點，企業可以透過調整採購策略來應對，例如增加關鍵零件的本地庫存緩衝、轉向擁有區域製造地的供應商，或修改合約以納入與貿易措施相關的價格調整機制。雖然這些戰術性應對措施有助於降低風險，但可能會增加營運成本需求並使物流變得複雜。策略性因應措施可以包括投資關鍵次組件的本地組裝能力，或深化與能夠提供雙重採購保證或專有材料檢驗的等效產品的供應商的夥伴關係夥伴關係。

監管和合規考量也與應對關稅息息相關。跨境採購時，企業必須確保物料可追溯性、分析證書要求以及變更控管程序的穩健性。積極主動地將供應鏈管治與預期政策情境結合的企業將保持更高的營運韌性，並降低生產中斷的風險。最終，關稅將影響成本結構和採購選擇，但最成功的企業將貿易措施視為更廣泛的韌性和供應商管理策略中的變數。

深度細分情報，揭示產品、工作流程、應用程式和最終用戶的區別，從而推動採購、部署和創新的優先級

要了解需求和部署模式，需要採用細緻的細分方法，將產品、工作流程、應用和最終用戶與採購和技術優先順序保持一致。從產品角度來看，生物反應器、層析法系統、過濾系統以及混合、儲存和填充系統等設備和工廠組件是資本和整合規劃的核心。生物反應器的尺寸範圍從1000公升以下到1001公升、2000公升以及2000公升以上，這會影響製程設計和供應鏈的複雜性。袋子、探頭和感測器、採樣系統、管道、過濾器、連接器和傳輸系統等簡單和周邊組件對於運行可靠性至關重要，其中探頭和感測器涵蓋電導率、流量、氧氣、pH值、壓力和溫度測量。細胞培養系統和注射器等營運設備類別具有獨特的採購週期和檢驗路徑，這些與設施設計選擇相交叉。

從工作流程階段的角度來看，上游工程、下游、填充和表面處理工程以及品管與分析之間的差異決定了組織如何分配資本和技術資源。上游工程通常要求密閉性、無菌性和感測器整合等，而下游流程則強調淨化能力、一次性層析法和過濾耗材等。此外，品管工作流程需要有效的採樣、分析和可追溯性，以滿足監管要求。

無菌填充、細胞培養、過濾、混合、純化、取樣和儲存對材料、相容性測試和操作員培訓的要求各不相同。最終用戶涵蓋製藥和生物技術公司、學術和研究機構、契約製造和研究組織，其實施方法的風險狀況、檢驗能力和預算限制各不相同。結合這些細分維度，可以揭示供應商應將產品開發重點放在哪裡，整合商應如何配置其系統，以及為什麼買家在選擇一次性解決方案時必須平衡技術相容性、法規遵循和服務承諾。

美洲、歐洲、中東和非洲以及亞太地區的招聘趨勢、法規環境和生產能力的詳細展望

每個地區的促進因素將顯著不同地影響其應用、法規和供應鏈設計，因此需要高階主管根據地理叢集客製化策略。在美洲，強大的製造外包網路、成熟的法律規範以及叢集的集中，正在推動拋棄式在臨床和商業製造領域的快速應用。北美公司往往優先考慮臨床速度和整合供應商關係，青睞那些提供承包系統和驗證支援的供應商。

歐洲、中東和非洲地區監管體係錯綜複雜，高度重視永續性和生命週期評估。嚴格的監管和日益成長的環境影響擔憂，迫使相關人員在一次性和可重複使用系統之間進行權衡，這通常鼓勵採用將一次性用品與集中式公用事業和廢棄物管理策略相結合的混合方案。該地區也積極開展公私舉措，旨在增強製造業的韌性，並拓展本地在先進療法方面的能力。

受產能快速擴張、政府支持的生物製造計劃以及契約製造數量的成長推動，亞太地區呈現出多樣化的採用模式。對本地生產的投資不斷增加以及縮短供應鏈的願望，正在推動與能夠進行本地生產和本地組裝的供應商建立合作夥伴關係，以滿足產量和資格確認時間表。在所有地區，監管協調工作和跨境供應鏈規劃對於有效擴大一次性產品的部署仍然至關重要。

競爭格局：重點介紹推動創新、夥伴關係和整合的領先製造商、系統整合商和服務供應商

一次性生物製程的競爭態勢體現出一種連續性，從專業元件供應商到全方位系統整合商和服務供應商。大型設備製造商持續投資於強大的一次性平台，同時擴展感測器和分析能力，以滿足流程視覺化和法規遵循的需求。同時，越來越多的利基供應商專注於高效能耗材，例如一次性過濾介質、專用連接器和先進的管材；這些公司在技術差異化和與舊有系統的有效相容性方面競爭。

服務供應商和承包商擴大透過提供檢驗支援、庫存管理和組裝服務來加入價值鏈，從而減輕買家的負擔。這種趨勢正在模糊傳統的供應商與客戶之間的界限，企業正在尋求包含安裝、培訓和生命週期支援的捆綁式服務。夥伴關係和策略聯盟日益普遍，技術交叉授權和共同開發契約加快了整合解決方案的上市時間。

最具活力的公司將卓越的工程技術與支援法規提交和持續供應的能力相結合。能夠展示嚴格的品質系統、記錄的可追溯性和強大的售後服務的公司，能夠更好地建立持久的商業關係。對於負責人而言，評估供應商的能力不僅需要評估產品效能，還需要評估供應商的全球佈局、檢驗套件以及在延長的產品生命週期內支援多站點部署的準備。

為行業領導者提供可行的策略建議，以最佳化供應鏈、加速採用並使商業模式與不斷發展的一次性使用動態保持一致

領導者應採取平衡的方法，保持靈活性，確保供應的連續性，並使技術選擇與監管義務一致。首先要建立跨職能管治，將採購、品質、工程和營運部門整合在一起，全面評估一次性產品的採用決策。此管治應規範供應商合格標準、變更管理觸發機制以及關鍵零件的應急計劃，以降低意外中斷的風險。

其次，盡可能優先考慮雙重採購和區域供應商關係，以降低貿易和物流風險，同時協商包含服務水準預期和檢驗交付成果的長期承諾。投資內部整合和資格確認能力，避免合作夥伴交接成為瓶頸。開發內部專業知識（例如一次性組裝、共用公用設施清潔和分析）的組織可以縮短部署週期並減少外部依賴。

最後，將永續性和生命週期分析融入採購決策中，確定一次性用品在哪些方面能夠顯著降低能源、水或污染風險，以及混合模式在哪些方面能夠帶來最佳的整體效益。鼓勵供應商提供詳細的材料聲明和物料輸送方案，並將這些考慮納入資本計畫和供應商記分卡，以推動整個供應體系的持續改進。

調查方法概述：描述報告研究結果所依據的主要和次要研究方法、檢驗方法和分析框架

這項研究採用了混合方法，結合了初步研究、供應商和最終用戶分析以及嚴格的二手資料檢驗，以確保分析反映商業現實。初步研究包括與不同組織的技術負責人、採購主管和營運經理進行結構化討論，以了解影響一次性產品採用的決策促進因素、痛點和切實可行的解決方案。這些第一手的見解構成了以技術就緒性、供應鏈韌性和監管考量為重點的主題分析的基礎。

二次研究包括針對性地審查技術文獻、標準出版物和監管指南文件，以檢驗技術聲明並繪製通用的資格認證路徑。數據三角測量和交叉檢驗步驟確保報告的趨勢代表廣泛的行業情緒，而不是孤立的經驗。調查方法也運用情境分析來探討採購、關稅和區域變數如何與業務重點相互影響。

品質保證流程包括專家同行評審和最終編輯，重點關注技術準確性和清晰度。最終的分析框架將策略要務與營運行動相聯繫，並為內部基準基準化分析和供應商評估提供可重複的依據，從而為決策者提供支援。

對不斷發展的一次性生物製程系統中指導高階主管決策的策略要務和營運要點的最終綜合

一次性生物製程具有操作靈活性、污染控制和模組化擴充性等極具吸引力的特性，但要充分發揮其潛力，需要嚴格的供應商管治和系統性規劃。成功的實施者會結合技術評估、策略性供應商參與和強大的驗證框架，使製程設計選擇與監管和業務目標保持一致。結論部分總結了報告的核心主題，並強調了最有效降低風險和加速效益實現的優先行動。

隨著企業不斷完善其一次性系統方案，對供應鏈彈性、本地監管細節以及整合服務產品的關注將決定領導者與追隨者之間的差異。高階主管應將向一次性用品的過渡視為一項涵蓋採購、品質、工程和永續性議題的系統性變革，而非一系列的點式採購。透過週詳的規劃以及對人員和流程的有針對性的投資，一次性技術的營運效益得以實現，同時又能維持合規性、可預測性和成本控制。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 一次性生物反應器在基因和細胞治療規模化環境中的快速應用
  • 將線上感測器和數位分析整合到一次性生物處理系統中
  • 制定一次性生物製程耗材的永續處置和回收策略
  • 擴展一次性技術以減少大規模單株抗體生產中的停機時間
  • 全球生物製藥市場一次性系統檢驗的監管協調挑戰
  • 供應鏈中斷對持續生物製造所需的一次性零件供應的影響
  • 混合不銹鋼和一次性平台的出現，實現了靈活、即插即用的生物生產
  • 使用新型聚合物材料改善一次性系統中的萃取物和可浸出特性
  • 一次性過濾過濾技術的進步提高了病毒去除率和產品純度
  • 學術界和工業界合作夥伴合作開發模組化一次性平台

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 一次性生物製程市場（依產品類型）

  • 設備和設施
    • 生物反應器
      • 1001L至2000L
      • 2000L以上
      • 最大1000公升
    • 層析法系統
    • 過濾系統
    • 混合、儲存和填充系統
    • 泵浦
  • 簡單和外圍元素
    • 包包
    • 探頭和感測器
      • 電導率感測器
      • 流量感測器
      • 氧氣感測器
      • pH感測器
      • 壓力感測器
      • 溫度感測器
    • 採樣系統
    • 管道、過濾器、連接器、傳輸系統
  • 工作設備
    • 細胞培養系統
    • 注射器

9. 一次性生物製程市場（依工作流程階段）

  • 下游加工
  • 灌裝和表面處理工程
  • 品管與分析
  • 上游處理

10. 一次性生物製程市場生物加工模式

  • 批次
  • 流體化床
  • 灌注

第 11 章一次性生物製程市場（按應用）

  • 無菌灌裝
  • 細胞培養
  • 濾
  • 混合物
  • 純化
  • 取樣
  • 貯存

12. 一次性生物製程市場（依最終用戶）

  • 學術研究機構
  • 契約製造和研究組織
  • 製藥和生物技術公司

13. 一次性生物製程市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

14. 一次性生物製程市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 一次性生物製程市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Agilitech
    • Aseptic Group
    • Avantor, Inc.
    • Bionet Servicios Tecnicos SL
    • BioPharma Dynamics Ltd.
    • CellBios Healthcare & Lifesciences Pvt. Ltd.
    • Compagnie de Saint-Gobain
    • Corning Incorporated
    • Cytiva by Danaher Corporation
    • Entegris, Inc.
    • Eppendorf SE
    • Foxx Life Sciences
    • Freudenberg Group
    • Getinge AB
    • Kuehne+Nagel International AG
    • Lonza Group AG Ltd.
    • Meissner Corporation
    • Merck KGaA
    • Mettler-Toledo International Inc.
    • Parker-Hannifin Corporation
    • PBS Biotech, Inc.
    • PharmNXT Biotech
    • PSG Dover by Dover Corporation
    • Repligen Corporation
    • SaniSure
    • Satake Multimix Corporation
    • Single Use Support GmbH
    • Tekni-Plex, Inc.
    • Watson-Marlow Fluid Technology Solutions by Spirax Group PLC
    • AdvantaPure by NewAge Industries
Product Code: MRR-431752EA4978

The Single-use Bioprocessing Market is projected to grow by USD 59.77 billion at a CAGR of 16.19% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 17.99 billion
Estimated Year [2025] USD 20.81 billion
Forecast Year [2032] USD 59.77 billion
CAGR (%) 16.19%

Executive introduction to single-use bioprocessing technologies and market dynamics that frame strategic decisions for biomanufacturing leaders worldwide

Single-use bioprocessing has matured from an experimental approach into a core manufacturing paradigm for biologics development and commercial production. Over recent years, technological refinements, regulatory acceptance of disposable technologies, and shifting operational priorities have accelerated interest across developers, contract service providers, and established pharmaceutical manufacturers. This introduction outlines the context for why disposable systems matter now: they reduce cross-contamination risk, enable faster campaign turnaround, and offer modularity that supports flexible manufacturing footprints.

As organizations balance the need for speed with stringent quality controls, single-use solutions present trade-offs that require careful evaluation. Capital planning, material supply reliability, and integration with existing stainless-steel assets present practical considerations that shape implementation timelines. The introduction also previews themes that recur throughout the analysis, including lifecycle sustainability, digital instrumentation and sensors, fill-finish decentralization, and the evolving role of suppliers as system integrators rather than component vendors.

Readers will find that appreciating the technology not only in isolation but as part of a broader biomanufacturing ecosystem clarifies where value accrues and where risks remain. Subsequent sections build on this foundation by examining the transformative shifts driving adoption, the implications of changing trade policy, the nuanced segmentation of demand, and the regional and competitive dynamics executives must weigh when defining their single-use strategies.

Emerging technological and operational inflection points reshaping single-use bioprocessing including digital integration, modular design, and sustainability drivers

The single-use bioprocessing landscape is undergoing transformative shifts driven by converging technological, regulatory, and commercial forces. Advances in materials science and sensor miniaturization have improved the reliability and analytics available within disposable assemblies, enabling closer process control and more reproducible outcomes. At the same time, digital integration-through improved connectivity, embedded probes, and remote monitoring-has made single-use systems compatible with modern automation frameworks, thus lowering the barrier to deployment in regulated production environments.

Operational models are also shifting. Manufacturers increasingly prefer modular, skidded solutions that can be scaled horizontally to meet variable demand rather than investing in large fixed-capacity stainless-steel facilities. This change supports fast product lifecycle transitions and contract manufacturing arrangements where rapid changeover and near-term flexibility matter most. Sustainability concerns and lifecycle assessment methodologies are placing new emphasis on material reuse where feasible, while also recognizing the energy and water savings that disposables can deliver over certain process footprints.

Moreover, supply chain resilience has moved to the top of procurement agendas. The industry is responding with supplier consolidation in some segments and with deeper partnerships in others, where vendors provide integrated systems, validation support, and inventory management services. These shifts create an imperative for biomanufacturers to reassess vendor selection criteria, governance models for technology transfer, and investment priorities that balance short-term agility with long-term operational continuity.

Comprehensive assessment of how United States tariff measures anticipated in 2025 could affect supply chains, sourcing strategies, and cost structures across single-use bioprocessing

Anticipated tariff actions and trade policy adjustments in the United States for 2025 have the potential to reverberate through single-use supply chains, influencing sourcing strategies and inventory management without altering the underlying value proposition of disposables. Tariff-driven cost pressures can prompt manufacturers to revisit their vendor diversification strategies, prioritize domestic sourcing options where feasible, and negotiate longer-term supply agreements to smooth price volatility. These adjustments, in turn, can alter lead times and increase emphasis on qualification of secondary suppliers to preserve continuity.

Importantly, companies may respond by adapting procurement tactics: increasing local inventory buffers for critical components, shifting to suppliers with regional manufacturing footprints, or revising contracts to include price adjustment mechanisms tied to trade measures. Such tactical responses help reduce exposure but can increase working capital requirements and complicate logistics. Strategic responses can include investing in local assembly capability for critical subassemblies or deepening partnerships with suppliers who can provide dual-sourcing assurances and validated equivalents for proprietary materials.

Regulatory and compliance considerations also intersect with tariff responses. When sourcing shifts across borders, companies must ensure that material traceability, certificate of analysis requirements, and change control procedures remain robust. Firms that proactively align their supply chain governance with expected policy scenarios will maintain higher operational resilience and reduce the risk of production disruption. Ultimately, while tariffs influence cost structures and sourcing choices, the most successful organizations will treat trade measures as one variable within a broader resilience and supplier management strategy.

Deep segmentation intelligence revealing product, workflow, application, and end-user distinctions that determine procurement, deployment, and innovation priorities

Understanding demand and deployment patterns requires a nuanced segmentation approach that aligns products, workflows, applications, and end users with procurement and technical priorities. From a product perspective, apparatus and plants including bioreactors, chromatography systems, filtration systems, mixing, storage, and filling systems occupy the core of capital and integration planning; bioreactor sizing choices from up to 1000L through 1001L to 2000L and above 2000L influence process design and supply chain complexity. Simple and peripheral elements such as bags, probes and sensors, sampling systems, along with tubing, filters, connectors, and transfer systems are essential to operational reliability, with probes and sensors covering conductivity, flow, oxygen, pH, pressure, and temperature measurement. Work equipment categories such as cell culture systems and syringes present their own procurement cycles and validation pathways that intersect with facility design choices.

When viewed through the lens of workflow stage, distinctions between upstream processing, downstream processing, fill-finish operations, and quality control and analytics determine how organizations allocate capital and technical resources. Upstream decisions often drive requirements for containment, sterility, and sensor integration, while downstream choices emphasize purification capacity and single-use chromatography and filtration consumables. Fill-finish operations necessitate robust aseptic strategies and equipment compatibility with closed-system disposables, and quality control workflows require validated sampling, analytics, and traceability to meet regulatory expectations.

Application-driven segmentation further refines priorities: aseptic filling, cell culture growth, filtration, mixing, purification, sampling, and storage each impose distinct demands on materials, compatibility testing, and operator training. End users, ranging from academic and research institutes to contract manufacturing and research organizations, as well as pharmaceutical and biotechnology companies, approach adoption with differing risk profiles, validation capabilities, and budgetary constraints. Together, these segmentation axes reveal where suppliers should focus product development, how integrators should configure systems, and why purchasers must balance technical fit, regulatory readiness, and service commitments when selecting single-use solutions.

Granular regional perspectives on adoption trajectories, regulatory environments, and capacity trends across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics shape adoption, regulation, and supply chain design in materially different ways, requiring executives to tailor strategies for each geographic cluster. In the Americas, strong contract manufacturing networks, a mature regulatory framework, and a concentration of biotech clusters drive rapid adoption of disposables for both clinical and commercial manufacturing. North American organizations tend to emphasize speed to clinic and integrated supplier relationships, which favors vendors offering turnkey systems and validation support.

Europe, Middle East & Africa presents a complex regulatory mosaic and a high focus on sustainability and lifecycle assessment. Regulatory stringency combined with heightened attention to environmental impact pushes stakeholders to evaluate trade-offs between disposables and reusable systems, often prompting hybrid approaches that pair disposables with centralized utilities and waste management strategies. The region also demonstrates active public-private initiatives to bolster manufacturing resilience and to expand local capability in advanced therapies.

Asia-Pacific exhibits diverse adoption patterns driven by rapid capacity expansion, government-supported biomanufacturing initiatives, and a growing base of contract manufacturers. Increasing investment into local production and the desire to shorten supply chains encourage partnerships with suppliers capable of regional manufacturing or local assembly to meet throughput and qualification timelines. Across all regions, regulatory harmonization efforts and cross-border supply chain planning remain pivotal to scaling single-use deployments efficiently.

Competitive landscape synthesis highlighting leading manufacturers, system integrators, and service providers driving innovation, partnerships, and consolidation dynamics

Competitive dynamics in single-use bioprocessing reflect a continuum from specialized component suppliers to full-scope systems integrators and service providers. Leading equipment manufacturers continue to invest in robust disposable platforms while expanding sensor and analytics capabilities to meet demand for process visibility and regulatory compliance. At the same time, a growing number of niche suppliers focus on high-performance consumables such as single-use filtration media, specialized connectors, and advanced tubing materials; these firms compete on technical differentiation and validated compatibility with legacy systems.

Service providers and contract organizations increasingly participate in the value chain by offering validation support, inventory management, and assembly services that reduce purchaser burden. This trend blurs traditional supplier-customer boundaries as companies seek bundled offerings that include installation, training, and lifecycle support. Partnerships and strategic alliances are common, with technology cross-licensing and co-development agreements accelerating time-to-market for integrated solutions.

The fastest-moving companies combine engineering excellence with an ability to support regulatory submissions and supply continuity. Firms that can demonstrate rigorous quality systems, documented traceability, and robust after-sales service establish durable commercial relationships. For purchasers, assessing supplier capability now requires evaluating not only product performance but also the supplier's global footprint, validation toolkits, and readiness to support multi-site deployments over extended product lifecycles.

Actionable strategic recommendations for industry leaders to optimize supply chains, accelerate adoption, and align commercial models with evolving single-use dynamics

Leaders should pursue a balanced approach that preserves flexibility, ensures supply continuity, and aligns technical choices with regulatory obligations. Begin by establishing cross-functional governance that brings together procurement, quality, engineering, and operations to evaluate single-use adoption decisions holistically. This governance should codify supplier qualification criteria, change-control triggers, and contingency plans for critical components to reduce the risk of unexpected disruptions.

Next, prioritize dual-sourcing and regional supplier relationships where feasible to mitigate trade and logistic exposures while negotiating long-term commitments that include service-level expectations and validation artifacts. Invest in internal capabilities for integration and qualification so that partner handoffs do not become bottlenecks; organizations that develop in-house expertise in single-use assembly, cleaning of shared utilities, and analytics will shorten deployment cycles and reduce external dependency.

Finally, integrate sustainability and lifecycle analysis into procurement decisions to identify where disposables demonstrably reduce energy, water, or contamination risk, and where hybrid models provide the best total impact. Encourage suppliers to provide detailed material declarations and end-of-life handling programs, and embed those considerations into capital planning and vendor scorecards to drive continuous improvement across the supply base.

Methodological overview explaining primary and secondary research approaches, validation techniques, and analytical frameworks that underpin the report's findings

The research synthesis relies on a mixed-methods approach combining primary interviews, supplier and end-user profiling, and rigorous secondary-source validation to ensure the analysis reflects operational realities. Primary research involved structured discussions with technical leaders, procurement heads, and operations managers across a range of organizations to capture decision drivers, pain points, and practical workarounds that influence single-use adoption. These firsthand insights anchored thematic analysis around technology readiness, supply chain resilience, and regulatory considerations.

Secondary research included targeted reviews of technical literature, standards publications, and regulatory guidance documents to validate technical claims and to map common qualification pathways. Data triangulation and cross-validation steps ensured that reported trends represent broad industry sentiment rather than isolated experiences. The methodology also applied scenario analysis to examine how sourcing, tariff, and regional variables interact with operational priorities, while preserving confidentiality and anonymization for all contributing interviewees.

Quality assurance processes encompassed peer review by subject-matter experts and a final editorial pass focusing on technical accuracy and clarity. The resulting analytical framework supports decision-makers by linking strategic imperatives to operational actions and by providing a reproducible basis for internal benchmarking and supplier evaluation exercises.

Conclusive synthesis of strategic imperatives and operational takeaways to guide executive decisions in the evolving single-use bioprocessing ecosystem

In closing, the imperative for executives is clear: single-use bioprocessing presents a compelling mix of operational flexibility, contamination control, and modular scalability, yet it requires disciplined supplier governance and systemic planning to realize its potential. Successful adopters couple technological evaluation with strategic supplier engagement and robust validation frameworks, thereby aligning process design choices with regulatory and business objectives. The conclusion consolidates the report's central themes and reinforces the priority actions that will most effectively reduce risk and accelerate benefit realization.

As organizations refine their approach to single-use systems, attention to supply chain resilience, regional regulatory nuance, and integrated service offerings will distinguish leaders from followers. Executives should treat the transition to disposables as a programmatic change that spans procurement, quality, engineering, and sustainability agendas rather than a series of isolated purchases. With thoughtful planning and targeted investment in people and processes, the operational advantages of single-use technologies can be achieved while maintaining compliance, predictability, and cost discipline.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rapid adoption of single-use bioreactors in gene and cell therapy scale-up environments
  • 5.2. Integration of inline sensors and digital analytics into disposable bioprocessing systems
  • 5.3. Development of sustainable disposal and recycling strategies for single-use bioprocessing consumables
  • 5.4. Expansion of single-use technologies in large-scale monoclonal antibody manufacturing to reduce downtime
  • 5.5. Regulatory harmonization challenges for single-use systems validation across global biopharma markets
  • 5.6. Impact of supply chain disruptions on availability of single-use components for biomanufacturing continuity
  • 5.7. Emergence of hybrid stainless steel and single-use platforms for flexible plug-and-play bioproduction
  • 5.8. Use of novel polymer materials to improve extractables and leachables profiles in disposable systems
  • 5.9. Advances in single-use downstream filtration to enhance virus removal and product purity
  • 5.10. Co-development of modular single-use platforms by academic and industry partners

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Single-use Bioprocessing Market, by Product Type

  • 8.1. Apparatus & Plants
    • 8.1.1. Bioreactors
      • 8.1.1.1. 1001L to 2000L
      • 8.1.1.2. Above 2000L
      • 8.1.1.3. Upto 1000L
    • 8.1.2. Chromatography Systems
    • 8.1.3. Filtration System
    • 8.1.4. Mixing, Storage, & Filling Systems
    • 8.1.5. Pumps
  • 8.2. Simple & Peripheral Elements
    • 8.2.1. Bags
    • 8.2.2. Probes & Sensors
      • 8.2.2.1. Conductivity Sensors
      • 8.2.2.2. Flow Sensors
      • 8.2.2.3. Oxygen Sensor
      • 8.2.2.4. pH Sensor
      • 8.2.2.5. Pressure Sensors
      • 8.2.2.6. Temperature Sensors
    • 8.2.3. Sampling Systems
    • 8.2.4. Tubing, Filters, Connectors, & Transfer Systems
  • 8.3. Work Equipment
    • 8.3.1. Cell Culture System
    • 8.3.2. Syringes

9. Single-use Bioprocessing Market, by Workflow Stage

  • 9.1. Downstream Processing
  • 9.2. Fill-Finish Operations
  • 9.3. Quality Control & Analytics
  • 9.4. Upstream Processing

10. Single-use Bioprocessing Market, by Bioprocess Mode

  • 10.1. Batch
  • 10.2. Fed-Batch
  • 10.3. Perfusion

11. Single-use Bioprocessing Market, by Application

  • 11.1. Aseptic Filling
  • 11.2. Cell Culture
  • 11.3. Filtration
  • 11.4. Mixing
  • 11.5. Purification
  • 11.6. Sampling
  • 11.7. Storage

12. Single-use Bioprocessing Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Contract Manufacturing Organizations & Contract Research Organizations
  • 12.3. Pharmaceutical & Biotechnology Companies

13. Single-use Bioprocessing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Single-use Bioprocessing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Single-use Bioprocessing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Sartorius AG
    • 16.3.2. Thermo Fisher Scientific Inc.
    • 16.3.3. Agilitech
    • 16.3.4. Aseptic Group
    • 16.3.5. Avantor, Inc.
    • 16.3.6. Bionet Servicios Tecnicos SL
    • 16.3.7. BioPharma Dynamics Ltd.
    • 16.3.8. CellBios Healthcare & Lifesciences Pvt. Ltd.
    • 16.3.9. Compagnie de Saint-Gobain
    • 16.3.10. Corning Incorporated
    • 16.3.11. Cytiva by Danaher Corporation
    • 16.3.12. Entegris, Inc.
    • 16.3.13. Eppendorf SE
    • 16.3.14. Foxx Life Sciences
    • 16.3.15. Freudenberg Group
    • 16.3.16. Getinge AB
    • 16.3.17. Kuehne + Nagel International AG
    • 16.3.18. Lonza Group AG Ltd.
    • 16.3.19. Meissner Corporation
    • 16.3.20. Merck KGaA
    • 16.3.21. Mettler-Toledo International Inc.
    • 16.3.22. Parker-Hannifin Corporation
    • 16.3.23. PBS Biotech, Inc.
    • 16.3.24. PharmNXT Biotech
    • 16.3.25. PSG Dover by Dover Corporation
    • 16.3.26. Repligen Corporation
    • 16.3.27. SaniSure
    • 16.3.28. Satake Multimix Corporation
    • 16.3.29. Single Use Support GmbH
    • 16.3.30. Tekni-Plex, Inc.
    • 16.3.31. Watson-Marlow Fluid Technology Solutions by Spirax Group PLC
    • 16.3.32. AdvantaPure by NewAge Industries

LIST OF FIGURES

  • FIGURE 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. SINGLE-USE BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. SINGLE-USE BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SINGLE-USE BIOPROCESSING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 1001L TO 2000L, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 1001L TO 2000L, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 1001L TO 2000L, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 1001L TO 2000L, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 1001L TO 2000L, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 1001L TO 2000L, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ABOVE 2000L, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ABOVE 2000L, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ABOVE 2000L, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ABOVE 2000L, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ABOVE 2000L, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ABOVE 2000L, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPTO 1000L, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPTO 1000L, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPTO 1000L, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPTO 1000L, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPTO 1000L, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPTO 1000L, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, STORAGE, & FILLING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, STORAGE, & FILLING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, STORAGE, & FILLING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, STORAGE, & FILLING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, STORAGE, & FILLING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, STORAGE, & FILLING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONDUCTIVITY SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONDUCTIVITY SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONDUCTIVITY SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONDUCTIVITY SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONDUCTIVITY SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONDUCTIVITY SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FLOW SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FLOW SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FLOW SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FLOW SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FLOW SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FLOW SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OXYGEN SENSOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OXYGEN SENSOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OXYGEN SENSOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OXYGEN SENSOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OXYGEN SENSOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OXYGEN SENSOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PH SENSOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PH SENSOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PH SENSOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PH SENSOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PH SENSOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PH SENSOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRESSURE SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRESSURE SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRESSURE SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRESSURE SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRESSURE SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRESSURE SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TEMPERATURE SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TEMPERATURE SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TEMPERATURE SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TEMPERATURE SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TEMPERATURE SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TEMPERATURE SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, FILTERS, CONNECTORS, & TRANSFER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, FILTERS, CONNECTORS, & TRANSFER SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, FILTERS, CONNECTORS, & TRANSFER SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, FILTERS, CONNECTORS, & TRANSFER SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, FILTERS, CONNECTORS, & TRANSFER SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, FILTERS, CONNECTORS, & TRANSFER SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SYRINGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SYRINGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SYRINGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SYRINGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SYRINGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SYRINGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL ELEMENTS, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY PROBES & SENSORS, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORK EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPARATUS & PLANTS, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTORS, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SIMPLE & PERIPHERAL